rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Xiangmin Cui

Director

Company insider

Files Form 4 as: Director, Nuvation Bio; 10% owner, BeyondSpring; Director and 10% owner, Alpine Immune Sciences; Director, Cue Health; Director, ARMO BioSciences; Director, China Biologic Products.

Every Form 4 they filed

In numbers

Trades disclosed
74
Buys
6
Sells
24
Bought
$21.5M
Sold
$1.2M
Companies
6
Companies where not an officer
6
First trade
11 Jul 2010
Last trade
21 May 2026
Last filed
26 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NUVB Nuvation BioDirector · Biotechnology · last 21 May 20264 buys · 0 sells
BYSI BeyondSpring10% owner · Biotechnology · last 2 Oct 20250 buys · 24 sells
Alpine Immune SciencesDirector, 10% owner · last 18 Jan 20242 buys · 0 sells
Cue HealthDirector · last 28 Sep 20210 buys · 0 sells
ARMO BioSciencesDirector · last 22 Jun 20180 buys · 0 sells
China Biologic ProductsDirector · last 1 Jan 20110 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
90Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 26 May 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—123,397 at $0.00filing
21 May 2026filed 26 May 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—123,397 at $0.00filing
27 Feb 2026filed 26 May 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—76,923 at $0.00filing
27 Feb 2026filed 26 May 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—76,923 at $0.00filing
27 Feb 2026filed 3 Mar 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—74,813 at $0.00filing
27 Feb 2026filed 3 Mar 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—74,813 at $0.00filing
2 Oct 2025filed 2 Oct 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$1,038600 at $1.73filing
1 Oct 2025filed 2 Oct 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$4,6822,601 at $1.80filing
30 Sep 2025filed 2 Oct 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$8,0804,464 at $1.81filing
3 Sep 2025filed 3 Sep 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$2,2991,270 at $1.81filing
2 Sep 2025filed 3 Sep 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$4,9842,800 at $1.78filing
29 Aug 2025filed 3 Sep 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$1,392800 at $1.74filing
15 Aug 2025filed 15 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$5,8002,900 at $2.00filing
14 Aug 2025filed 15 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$4,0002,000 at $2.00filing
4 Aug 2025filed 11 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$4,7872,196 at $2.18filing
18 Jul 2025filed 11 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$1,980900 at $2.20filing
17 Jul 2025filed 11 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$45K20,572 at $2.19filing
16 Jul 2025filed 11 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$12K5,396 at $2.24filing
15 Jul 2025filed 11 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$4,9072,152 at $2.28filing
14 Jul 2025filed 11 Aug 2025BYSI BeyondSpringBiotechnologySEC FORM 4 Sold$1,834801 at $2.29filing

Sectors

Health Care28
Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Gary HattersleyChief Scientific Officer · Chief Scientific Officer at Nuvation Bio, filing Form 4 there in the last year
Philippe SauvageChief Financial Officer · Chief Financial Officer at Nuvation Bio, filing Form 4 there in the last year
Stacy MarkelChief People Officer · Chief People Officer at Nuvation Bio, filing Form 4 there in the last year
Kerry WentworthChief Regulatory Officer · Chief Regulatory Officer at Nuvation Bio, filing Form 4 there in the last year
Robert MashalDirector · Director at Nuvation Bio, filing Form 4 there in the last year